 |
|
Isolated, Chronic, Epilepsia Partialis Continua in an HIV-Infected Patient
F. Bartolomei, MD, PhD;
M. Gavaret, MD;
C. Dhiver, MD;
J. A. Gastaut, MD;
D. Gambarelli, MD;
D. Figarell-Branger, MD, PhD;
J. L. Gastaut, MD
Arch Neurol. 1999;56:111-114.
Backgound The characteristic clinical feature of epilepsia partialis continua (EPC) is chronic focal myoclonus, usually involving the distal part of one extremity. A variety of pathogenetic factors have been implicated in EPC. In children, the most common cause is Rasmussen encephalitis; in adults, it is vascular disease or tumor involving the sensorimotor cortex. Epileptic seizures are a relatively common manifestation of central nervous system involvement in patients infected with human immunodeficiency virus (HIV), but, to our knowledge, isolated, chronic EPC has not been previously reported.
Objective To describe a case of typical EPC in a patient infected with HIV.
Design and Setting Case report from an epilepsy center.
Patient A 58-year-old man infected with HIV had continuous myoclonus that involved the right arm and was associated with intermittent motor seizures. The electroencephalographic findings were normal at the onset of the symptoms, but left central theta rhythm appeared later. Serial magnetic resonance imaging scans obtained over a 3-month period showed a progressively increasing left rolandic T2-weighted hypersignal. Histologic study of a stereotactic biopsy specimen demonstrated inflammation characterized by perivascular mononuclear cell infiltration. The only detectable cause was HIV infection. Immunocytochemical tests ruled out JC virus. Neuropsychological testing showed no evidence of cognitive impairment. An electroencephalographic-electromyographic "back-averaging" study showed a reproducible transient left biphasic complex preceding the bursts by about 30 milliseconds on the C3 and F3 electrodes, thus demonstrating that the myoclonus was of cortical origin. High-dose corticosteroid (prednisone, 100 mg/d) and anti–HIV-1 therapy led to marked radiological and clinical improvement. Infection with HIV enhances the risk of seizures, but, to our knowledge, this is the first reported case of "inflammatory" EPC.
Conclusions The present case suggests that the possibility of central nervous system involvement by HIV-1 should be taken into account in the diagnostic workup of patients with EPC. This case also indicates that treatment can be effective.
From the Centre Saint-Paul for Epilepsy (Drs Bartolomei, Gavaret, and J. L. Gastaut), the Department of Neurophysiology and Neuropsychology, Université de la Méditerranée (Dr Bartolomei), the Centre d'Information et de Soins pour l'Immunodéficience Humaine, Hôpital Sainte-Marguerite (Drs Dhiver and J. A. Gastaut), and the Department of Pathology, Centre Hospitalier Universitaire Timone (Drs Gambarelli and Figarella-Branger), Marseille, France.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(1):129-131.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement
Bien et al.
Brain 2005;128:454-471.
ABSTRACT
| FULL TEXT
|
